Edward Jordan Biography and Net Worth

Mr. Jordan is a global biotech visionary and courageous commercial leader with experience and demonstrated success in building biotech organizations and leading commercial organizations. His therapeutic drug categories expertise includes immunology, allergy, oncology, hematology, women’s health care, cardiovascular, endocrinology, pulmonary, and primary care. As Humanigen's Chief Commercial Officer he is a company officer and charged with building the commercial infrastructure, establishing a therapeutic category and preparing for the potential Emergency Use Authorization of lenzilumab for the treatment of Covid-19. Prior at DBV, he developed a new biotech therapeutic market, established DBV as a leader in food allergy, developed the commercial strategy and built the US organization. At AMAG, he served as SVP, Commercial, leading oncology and hematology products and lifecycle strategy / launch strategy. He advanced sales and profitability by double digits, successfully managed complex distribution, and pricing. He positioned the Company to double sales through a broader FDA label; maintained commercialization for a flagship product in the domestic market by managing a significant global label change; played a key role in doubling the Company’s size with a $600M+ acquisition; was a company officer and supported the Board of Directors.
Earlier, at Teva Pharmaceuticals, Mr. Jordan served as Head of Sales, Marketing & Training–Women’s Health Care, branded business, directing device, RX and OTC sales; managed a potential crisis of losing the flagship product by re-engineering the commercial team, go-to market strategy, and gained approval for the first OTC emergency contraceptive.
Before, Mr. Jordan served at Schering-Plough (now Merck) for seventeen years in several commercial and operational roles.
Mr. Jordan has an MBA from Southern New Hampshire University, and double BS degrees from The University of Rhode Island.